US Patent 11052144 Methods of tumor vaccination
Patent 11052144 was granted and assigned to DCPrime on July, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+531 characters)
Article
Patent abstract
A method for treating a tumor or generating an immune response against a tumor in a subject in need including a vaccination step comprising administration of a first composition, and a tumor-marking step comprising administration of a second composition, is provided. The first and second composition each comprises an antigenic polypeptide (e.g., a non-tumor antigen) or a nucleic acid encoding an antigenic polypeptide. Also provided are antigenic polypeptides and compositions for use in methods described herein.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Erik Hans Manting0
Satwinder Kaur Singh0
Vinod Sommandas0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110521440
Date of Patent
July 6, 2021
0Patent Application Number
168578510
Date Filed
April 24, 2020
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11052144 Methods of tumor vaccination
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11052144
Date of patent
July 6, 2021
Patent application number
16857851
Date Filed
April 24, 2020
Patent primary examiner
Find more entities like US Patent 11052144 Methods of tumor vaccination
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.